Vanda Pharmaceuticals Inc (VNDA) Annual Income Statement (USD)
VNDA Quarterly Financials (USD)
Frequently Asked Questions About Vanda Pharmaceuticals Inc (VNDA) Stock
Vanda Pharmaceuticals Inc's (VNDA) last reported annual revenue was USD 198.77 Million.
Vanda Pharmaceuticals Inc's (VNDA) annual revenue growth rate based on the revenue reported in the past 5 years is : -2.64%
Vanda Pharmaceuticals Inc's(VNDA) is not profitable as of its last reported annual financials.
The net profit margin for Vanda Pharmaceuticals Inc's(VNDA) from its laster reported year is -9.51%
The return on equity (ROE) for Vanda Pharmaceuticals Inc's(VNDA) from its last reported annual financials is : -3.02%
The return on assets (ROA) for Vanda Pharmaceuticals Inc's(VNDA) from its last reported annual financials is : -3.64%
The return on invested capital (ROIC) for Vanda Pharmaceuticals Inc's(VNDA) from its last reported annual financials is : -6.76%
The Debt to Equity ratio for Vanda Pharmaceuticals Inc's(VNDA) from its last reported annual financials is : 0.00%
The dividend yield for Vanda Pharmaceuticals Inc's(VNDA) from its laster reported year is 0.00%
Vanda Pharmaceuticals Inc's(VNDA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VNDA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
